Ischemic Preconditioning Claudication Study

NCT03511157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-12-14

No results posted yet for this study

Summary

This study proposes ischemic preconditioning (IPC) as a novel intervention to improve walking distance in patients with intermittent claudication.

Conditions

  • Intermittent Claudication
  • Ischemia Vascular
  • Peripheral Arterial Disease
  • Peripheral Vascular Disease

Interventions

OTHER

Ischemic Preconditioning

See Ischemic Preconditioning Experimental group description

OTHER

Control Group

See Control group description

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-14
Primary Completion
2022-12-13
Completion
2022-12-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03511157 on ClinicalTrials.gov